{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T14:13:42Z","timestamp":1648995222200},"reference-count":37,"publisher":"Georg Thieme Verlag KG","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Klin Monbl Augenheilkd"],"published-print":{"date-parts":[[2020,11]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>\n          Background Optic neuritis is a special challenge to the ophthalmologist. It is a relatively frequent condition but difficult to seize morphologically. It has neurological implications and is subject matter of recent trials.<\/jats:p><jats:p>\n          Methods Selective literature search including the authors\u02bc professional experience.<\/jats:p><jats:p>\n          Results Practical aids for the ophthalmological management of optic neuritis are derived from the best available evidence and the recent literature is discussed.<\/jats:p><jats:p>\n          Conclusions The present paper provides evidence-based recommendations for a safe handling of optic neuritis as well as information on current issues.<\/jats:p>","DOI":"10.1055\/a-1276-1728","type":"journal-article","created":{"date-parts":[[2020,11,18]],"date-time":"2020-11-18T03:50:22Z","timestamp":1605671422000},"page":"1286-1289","source":"Crossref","is-referenced-by-count":0,"title":["Current Recommendations on Optic Neuritis"],"prefix":"10.1055","volume":"237","author":[{"given":"Flemming","family":"Beisse","sequence":"additional","affiliation":[{"name":"Augenheilkunde, Universit\u00e4tsklinikum Heidelberg, Deutschland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina","family":"Beisse","sequence":"additional","affiliation":[{"name":"Augenheilkunde, Universit\u00e4tsklinikum Heidelberg, Deutschland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2020,11,17]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S1474-4422(13)70259-X","article-title":"Optic neuritis","volume":"13","author":"A T Toosy","year":"2014","journal-title":"Lancet Neurol"},{"key":"ref2","first-page":"15","article-title":"Recurrent optic neuritis: clues from a long-term follow up study of recurrent and bilateral optic neuritis patients","volume":"2","author":"A Kurne","year":"2010","journal-title":"Eye Brain"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1098\/rstb.1999.0510","article-title":"The pathophysiology of multiple sclerosis: the\u00a0mechanisms underlying the production of symptoms and the natural history of the disease","volume":"354","author":"K J Smith","year":"1999","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/0002-9394(54)92198-4","article-title":"Optic neuritis in relation to demyelinating diseases; a clinical study","volume":"37","author":"A Schlossman","year":"1954","journal-title":"Am J Ophthalmol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1001\/archopht.1991.01080120057025","article-title":"The clinical profile of optic neuritis. Experience of the Optic Neuritis Treatment Trial. Optic Neuritis Study Group","volume":"109","year":"1991","journal-title":"Arch Ophthal"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1056\/NEJM199202273260901","article-title":"A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. The Optic Neuritis Study Group","volume":"326","author":"R W Beck","year":"1992","journal-title":"N Engl J Med"},{"key":"ref8","volume-title":"Pupillenreaktionen \u2013 Pupillenst\u00f6rungen","author":"H Wilhelm","year":"1991"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1097\/WNO.0b013e31820cf78a","article-title":"Neuroretinitis: review of the literature and new observations","volume":"31","author":"V Purvin","year":"2011","journal-title":"J Neuroophthalmol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1007\/s11910-015-0598-1","article-title":"Atypical optic neuritis","volume":"15","author":"E D Gaier","year":"2015","journal-title":"Curr Neurol Neurosci Rep"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00415-013-7169-7","article-title":"Update on the diagnosis and treatment of neuromyelitis optica: recommendations of the Neuromyelitis Optica Study Group (NEMOS)","volume":"261","author":"C Trebst","year":"2014","journal-title":"J Neurol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1093\/brain\/awg045","article-title":"Chronic relapsing inflammatory optic neuropathy (CRION)","volume":"126","author":"D Kidd","year":"2003","journal-title":"Brain"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1007\/s00415-013-7166-x","article-title":"Differential diagnoses to MS: experiences from an optic neuritis clinic","volume":"261","author":"H Horwitz","year":"2014","journal-title":"J Neurol"},{"key":"ref14","first-page":"171","article-title":"Vergleich des Flimmertests nach Aulhorn mit den visuell evozierten Potentialen in der Diagnostik der Neuritis nervi optici","volume":"87","author":"S Trauzettel-Klosinski","year":"1990","journal-title":"Fortschr Ophthalmol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/j.clinph.2017.03.047","article-title":"Multifocal visual evoked potentials in optic neuritis and multiple sclerosis: A review","volume":"128","author":"G Pihl-Jensen","year":"2017","journal-title":"Clin Neurophysiol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.amjoto.2018.08.008","article-title":"Rhinogenous optic neuritis with full recovery of vision \u2013 The role of endoscopic optic nerve decompression and a review of literature","volume":"39","author":"W L Neo","year":"2018","journal-title":"Am J Otolaryngol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.neurol.2016.03.003","article-title":"Neuromyelitis optica spectrum disorder (NMOSD): A new concept","volume":"172","author":"J de S\u00e8ze","year":"2016","journal-title":"Rev Neurol (Paris)"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1097\/ICU.0000000000000520","article-title":"Myelin oligodendrocyte glycoprotein-IgG-associated optic neuritis","volume":"29","author":"B Y Chun","year":"2018","journal-title":"Curr Opin Ophthalmol"},{"key":"ref20","first-page":"59","article-title":"Infectious optic neuropathies: a clinical update","volume":"7","author":"R Kahloun","year":"2015","journal-title":"Eye Brain"},{"key":"ref21","first-page":"1422","article-title":"Infectious optic neuropathies","volume":"25","author":"E R Eggenberger","year":"2019","journal-title":"Continuum (Minneap Minn)"},{"issue":"08","key":"ref22","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001430.pub4","article-title":"Corticosteroids for treating optic neuritis","author":"R L Gal","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0197-2456(93)90015-6","article-title":"Design, methods, and conduct of the optic neuritis treatment trial","volume":"14","author":"P A Cleary","year":"1993","journal-title":"Control Clin Trials"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1136\/jnnp-2019-321653","article-title":"Case for a new corticosteroid treatment trial in optic neuritis: review of updated evidence","volume":"91","author":"A Petzold","year":"2020","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1212\/01.WNL.0000152873.82631.B3","article-title":"A double-blind, randomized trial of IV immunoglobulin treatment in acute optic neuritis","volume":"64","author":"H G Roed","year":"2005","journal-title":"Neurology"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S1474-4422(16)00004-1","article-title":"Phenytoin for neuroprotection in patients with acute optic neuritis: a randomised, placebo-controlled, phase 2 trial","volume":"15","author":"R Raftopoulos","year":"2016","journal-title":"Lancet Neurol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1177\/1352458511415452","article-title":"Simvastatin improves final visual outcome in acute optic neuritis: a randomized study","volume":"18","author":"A Tsakiri","year":"2012","journal-title":"Mult Scler"},{"key":"ref28","first-page":"2055217316641704","article-title":"Blocking LINGO-1 in vivo reduces degeneration and enhances regeneration of the optic nerve","volume":"2","author":"M M Gresle","year":"2016","journal-title":"Mult Scler J Exp Transl Clin"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1007\/s00417-011-1894-3","article-title":"Memantine for axonal loss of optic neuritis","volume":"250","author":"M R Esfahani","year":"2012","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/ana.23573","article-title":"A randomized, double-blind, phase 2 study of erythropoietin in optic neuritis","volume":"72","author":"K W Suhs","year":"2012","journal-title":"Ann Neurol"},{"key":"ref31","first-page":"299","article-title":"Visual outcomes of adding erythropoietin to methylprednisolone for treatment of retrobulbar optic neuritis","volume":"14","author":"M Soltan Sanjari","year":"2019","journal-title":"J Ophthalmic Vis Res"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"e010956","DOI":"10.1136\/bmjopen-2015-010956","article-title":"Treatment of optic neuritis with erythropoietin (TONE): a randomised, double-blind, placebo-controlled trial-study protocol","volume":"6","author":"R Diem","year":"2016","journal-title":"BMJ Open"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s10384-018-0561-1","article-title":"Diagnosis and treatment of anti-myelin oligodendrocyte glycoprotein antibody positive optic neuritis","volume":"62","author":"T Kezuka","year":"2018","journal-title":"Jpn J Ophthalmol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"S174","DOI":"10.1016\/j.ophtha.2020.01.027","article-title":"The course of visual recovery after optic neuritis: Experience of the optic neuritis treatment trial","volume":"127(4S)","author":"R W Beck","year":"2020","journal-title":"Ophthalmology"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1056\/NEJM199801293380502","article-title":"Axonal transection in the lesions of multiple sclerosis","volume":"338","author":"B D Trapp","year":"1998","journal-title":"N Engl J Med"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1002\/ana.20851","article-title":"Quantifying axonal loss after optic neuritis with optical coherence tomography","volume":"59","author":"F Costello","year":"2006","journal-title":"Ann Neurol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"101387","DOI":"10.1016\/j.msard.2019.101387","article-title":"Early neuroaxonal injury is seen in the acute phase of pediatric optic neuritis","volume":"36","author":"C Wilbur","year":"2019","journal-title":"Mult Scler Relat Disord"},{"key":"ref38","first-page":"727","article-title":"Multiple sclerosis risk after optic neuritis: final optic neuritis treatment trial follow-up","volume":"65","author":"Optic Neuritis Study Group","year":"2008","journal-title":"Arch Neurol"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1177\/1352458520917924","article-title":"Predictive value of optical coherence tomography, multifocal visual evoked potentials, and full-field visual evoked potentials of the fellow, non-symptomatic eye for subsequent multiple sclerosis development in patients with acute optic neuritis","author":"G Pihl-Jensen","year":"2020","journal-title":"Mult Scler"}],"container-title":["Klinische Monatsbl\u00e4tter f\u00fcr Augenheilkunde"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-1276-1728.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,18]],"date-time":"2020-11-18T03:51:28Z","timestamp":1605671488000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-1276-1728"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":37,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2020,11,17]]},"published-print":{"date-parts":[[2020,11]]}},"URL":"https:\/\/doi.org\/10.1055\/a-1276-1728","relation":{},"ISSN":["0023-2165","1439-3999"],"issn-type":[{"value":"0023-2165","type":"print"},{"value":"1439-3999","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11]]}}}